vte IN PATIENTS WITH COVID-19
April, 21, 2022. 17:00 h
VTE IN PATIENTS WITH COVID-19
April, 21, 2022. 17:00 hVTE IN PATIENTS WITH COVID-19
April, 21, 2022. 17:00 h
Free registration / Inscripción gratuita
Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance
17:00-17:15 h. WELCOME-PRESENTATION-OBJECTIVES
Dr. Manuel Monreal Bosch
Coordinator Project RIETE Registry
Department of Internal Medicine
University Hospital Germans Trias i Pujol
Badalona, Barcelona. Spain
Dr. Pablo Demelo Rodríguez
Department of Internal Medicine
University General Hospital Gregorio Marañón. Madrid. Spain
17:00-19:00 h. VTE IN PATIENTS WITH COVID-19
Chairman: Dr. Pablo Demelo Rodríguez
Department of Internal Medicine
University General Hospital Gregorio Marañón. Madrid. Spain
Clinical characteristics and outcomes of venous thromboembolism in COVID-19 patients
Dr. Behnood Bikdeli
Cardiovascular Medicine Division, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, Center for
Outcomes Research and Evaluation (CORE), Yale University
School of Medicine, New Haven, CT, Clinical Trials Center,
CardiovascSular Research Foundation, New York, NY, USA
Risk of bleeding in COVID-19 patients: can we do better?
Dr. Luís Jara Palomares
Department of Pneumonology
University Hospital Virgen del Rocío. Sevilla. Spain
Dr. Manuel Monreal Bosch
Coordinator Project RIETE Registry
Department of Internal Medicine
University Hospital Germans Trias i Pujol
Badalona, Barcelona. Spain
Dr. Pablo Demelo Rodríguez
Department of Internal Medicine
University General Hospital Gregorio Marañón. Madrid. Spain
Dr. Behnood Bikdeli
Cardiovascular Research Foundation, New York, NY, USA
Dr. Luís Jara Palomares
Department of Pneumonology
University Hospital Virgen del Rocío. Sevilla. Spain
Our goal is to launch a virtual interactive course aimed at national and international RIETE members and any other physicians interested in VTE.
The course will be in English.
The purpose of the course is to present the results on VTE in patients with COVID-19 from the RIETE Registry Database, as well as to present the new App tool which has been developed to help clinicians in their daily clinical practice.
The course will last 2 hours and will count with a chairman and two speakers who will deal with different aspects of VTE in patients with COVID-19.
The idea is that each Speaker makes a presentation of a maximum of 20 minutes and the remaining 40 minutes will be for discussion/questions.
COURSE OBJECTIVES
• To update attendees with the most recent data from the RIETE Registry on patients with COVID-19 who have developed VTE.
• To learn the RIETE App.
Society/Foundation that endorses the Course
The Course is organized by the Foundation for the Study of Thromboembolic Disease (FUENTE) under the auspices of the Association for the Study of Vascular Disease in Spain (ASEMEVE).
Any physicians interested in VTE is invited to register for free
